Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/05/20
Here's a Better Reason to Buy Gilead Sciences Stock Than a Possible Coronavirus TreatmentThe Motley Fool • 02/04/20
This Biotech Giant Is Planning Human Studies In Coronavirus In ChinaInvestors Business Daily • 02/03/20
Gilead's Experimental Antiviral Drug To Be Screened In Human Trials In China For CoronavirusBenzinga • 02/03/20